Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jalen Patel"'
Autor:
Hedyeh Ebrahimi, Daniela V. Castro, Matthew I. Feng, Sweta R. Prajapati, Kyle O. Lee, Elyse H. Chan, Trishita Paul, Ishaan Sehgal, Jalen Patel, Xiaochan Li, Zeynep B. Zengin, Luis Meza, Benjamin D. Mercier, JoAnn Hsu, Ameish Govindarajan, Neal Chawla, Nazli Dizman, Cristiane D Bergerot, Adam Rock, Sandy Liu, Abhishek Tripathi, Tanya Dorff, Sumanta K. Pal, Alexander Chehrazi-Raffle
Publikováno v:
Clinical Genitourinary Cancer.
Autor:
Ameish Govindarajan, Daniela V. Castro, Zeynep B. Zengin, Sabrina K. Salgia, Jalen Patel, Sumanta K. Pal
Publikováno v:
Cancers. 14(9)
Over the last decade, the treatment paradigm of metastatic renal cell carcinoma has rapidly evolved, with notable changes in the front-line setting. Combination therapies involving the use of either doublet therapy with immune checkpoint inhibitors o
Autor:
Matthew I. Feng, Sweta R. Prajapati, Daniela V. Castro, Kyle O. Lee, Elyse H. Chan, Ishaan Sehgal, Jalen Patel, Anna O'Dell, Zeynep Busra Zengin, Xiaochen Li, Alex Chehrazi-Raffle, Nazli Dizman, Abhishek Tripathi, Adam Rock, Sandy Liu, Benjamin D. Mercier, Luis A Meza, Errol James Philip, Tanya B. Dorff, Sumanta Monty Pal
Publikováno v:
Journal of Clinical Oncology. 41:34-34
34 Background: The American Society of Clinical Oncology (ASCO) and the Friends of Cancer Research (FCR) published a joint statement addressing clinical eligibility for characteristics lacking adequate representation in recent studies (Kim et al., Cl
Autor:
Sweta R. Prajapati, Matthew I. Feng, Daniela V. Castro, Kyle O. Lee, Elyse H. Chan, Ishaan Sehgal, Jalen Patel, Anna O'Dell, Zeynep Busra Zengin, Xiaochen Li, Alex Chehrazi-Raffle, Nazli Dizman, Abhishek Tripathi, Adam Rock, Sandy Liu, Benjamin D. Mercier, Luis A Meza, Errol James Philip, Tanya B. Dorff, Sumanta Monty Pal
Publikováno v:
Journal of Clinical Oncology. 41:612-612
612 Background: A consensus statement from the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (FCR) collaboration highlights the importance of expanding eligibility criteria in cancer trials to more accurately reflect the
Autor:
Daniela V. Castro, Matthew I. Feng, Sweta R. Prajapati, Elyse H. Chan, Kyle O. Lee, Ishaan Sehgal, Jalen Patel, Anna O'Dell, Zeynep Busra Zengin, Xiaochen Li, Alex Chehrazi-Raffle, Nazli Dizman, Abhishek Tripathi, Adam Rock, Sandy Liu, Benjamin D. Mercier, Luis A Meza, Errol James Philip, Tanya B. Dorff, Sumanta Monty Pal
Publikováno v:
Journal of Clinical Oncology. 41:453-453
453 Background: American Society of Clinical Oncology (ASCO) and the Friends of Cancer Research (FCR) underscored the need to broaden eligibility criteria in cancer trials to increase patient accrual, expand access to investigational treatments, and
Autor:
Iris Horng, Katelyn King, Jalen Patel, Kartik Pejavara, Kaushik Tallam, Thomas Emge, N. Sanjeeva Murthy
Publikováno v:
2019 IEEE MIT Undergraduate Research Technology Conference (URTC).